179 related articles for article (PubMed ID: 32872656)
1. Capsaicin Causes Vasorelaxation of Rat Aorta through Blocking of L-type Ca
Andrade F; Rangel-Sandoval C; Rodríguez-Hernández A; López-Dyck E; Elizalde A; Virgen-Ortiz A; Bonales-Alatorre E; Valencia-Cruz G; Sánchez-Pastor E
Molecules; 2020 Aug; 25(17):. PubMed ID: 32872656
[TBL] [Abstract][Full Text] [Related]
2. Cannabinoid receptor type 1 activation by arachidonylcyclopropylamide in rat aortic rings causes vasorelaxation involving calcium-activated potassium channel subunit alpha-1 and calcium channel, voltage-dependent, L type, alpha 1C subunit.
Sánchez-Pastor E; Andrade F; Sánchez-Pastor JM; Elizalde A; Huerta M; Virgen-Ortiz A; Trujillo X; Rodríguez-Hernández A
Eur J Pharmacol; 2014 Apr; 729():100-6. PubMed ID: 24561046
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms involved in oleamide-induced vasorelaxation in rat mesenteric resistance arteries.
Sudhahar V; Shaw S; Imig JD
Eur J Pharmacol; 2009 Apr; 607(1-3):143-50. PubMed ID: 19326479
[TBL] [Abstract][Full Text] [Related]
4. Vasorelaxation to capsaicin and its effects on calcium influx in arteries.
Hopps JJ; Dunn WR; Randall MD
Eur J Pharmacol; 2012 Apr; 681(1-3):88-93. PubMed ID: 22532967
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the vasorelaxant mechanisms of the endocannabinoid anandamide in rat aorta.
Herradón E; Martín MI; López-Miranda V
Br J Pharmacol; 2007 Nov; 152(5):699-708. PubMed ID: 17704831
[TBL] [Abstract][Full Text] [Related]
6. Cytochrome P450 pathway contributes to methanandamide-induced vasorelaxation in rat aorta.
López-Miranda V; Dannert MT; Herradón E; Alsasua A; Martín MI
Cardiovasc Drugs Ther; 2010 Dec; 24(5-6):379-89. PubMed ID: 20814734
[TBL] [Abstract][Full Text] [Related]
7. ACPA and JWH-133 modulate the vascular tone of superior mesenteric arteries through cannabinoid receptors, BK
López-Dyck E; Andrade-Urzúa F; Elizalde A; Ferrer-Villada T; Dagnino-Acosta A; Huerta M; Osuna-Calleros Z; Rangel-Sandoval C; Sánchez-Pastor E
Pharmacol Rep; 2017 Dec; 69(6):1131-1139. PubMed ID: 29128791
[TBL] [Abstract][Full Text] [Related]
8. Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors.
Golech SA; McCarron RM; Chen Y; Bembry J; Lenz F; Mechoulam R; Shohami E; Spatz M
Brain Res Mol Brain Res; 2004 Dec; 132(1):87-92. PubMed ID: 15548432
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of vasorelaxation induced by oleoylethanolamide in the rat small mesenteric artery.
AlSuleimani YM; Hiley CR
Eur J Pharmacol; 2013 Feb; 702(1-3):1-11. PubMed ID: 23340219
[TBL] [Abstract][Full Text] [Related]
10. Capsaicin evokes hypothermia independent of cannabinoid CB1 and CB2 receptors.
Ding Z; Cowan A; Rawls SM
Brain Res; 2005 Dec; 1065(1-2):147-51. PubMed ID: 16309633
[TBL] [Abstract][Full Text] [Related]
11. Noladin ether, a putative endocannabinoid, attenuates sensory neurotransmission in the rat isolated mesenteric arterial bed via a non-CB1/CB2 G(i/o) linked receptor.
Duncan M; Millns P; Smart D; Wright JE; Kendall DA; Ralevic V
Br J Pharmacol; 2004 Jun; 142(3):509-18. PubMed ID: 15148262
[TBL] [Abstract][Full Text] [Related]
12. TRPV1, TRPA1, and CB1 in the isolated vagus nerve--axonal chemosensitivity and control of neuropeptide release.
Weller K; Reeh PW; Sauer SK
Neuropeptides; 2011 Dec; 45(6):391-400. PubMed ID: 21868092
[TBL] [Abstract][Full Text] [Related]
13. TRPV
Ives SJ; Park SY; Kwon OS; Gifford JR; Andtbacka RHI; Hyngstrom JR; Richardson RS
Exp Physiol; 2017 Sep; 102(9):1245-1258. PubMed ID: 28681979
[TBL] [Abstract][Full Text] [Related]
14. Activation of cannabinoid CB1 receptors suppresses the ROS-induced hypersensitivity of rat vagal lung C-fiber afferents.
Yeh CM; Ruan T; Lin YJ; Hsu TH
Pulm Pharmacol Ther; 2016 Oct; 40():22-9. PubMed ID: 27328978
[TBL] [Abstract][Full Text] [Related]
15. Vascular pharmacology of a novel cannabinoid-like compound, 3-(5-dimethylcarbamoyl-pent-1-enyl)-N-(2-hydroxy-1-methyl-ethyl)benzamide (VSN16) in the rat.
Hoi PM; Visintin C; Okuyama M; Gardiner SM; Kaup SS; Bennett T; Baker D; Selwood DL; Hiley CR
Br J Pharmacol; 2007 Nov; 152(5):751-64. PubMed ID: 17891160
[TBL] [Abstract][Full Text] [Related]
16. The endocannabinoid anandamide causes endothelium-dependent vasorelaxation in human mesenteric arteries.
Stanley CP; Hind WH; Tufarelli C; O'Sullivan SE
Pharmacol Res; 2016 Nov; 113(Pt A):356-363. PubMed ID: 27633407
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the vasorelaxation to methanandamide in rat gastric arteries.
Breyne J; Van de Voorde J; Vanheel B
Can J Physiol Pharmacol; 2006 Nov; 84(11):1121-32. PubMed ID: 17218976
[TBL] [Abstract][Full Text] [Related]
18. The endogenous lipid N-arachidonoyl glycine is hypotensive and nitric oxide-cGMP-dependent vasorelaxant.
Al Suleimani YM; Al Mahruqi AS
Eur J Pharmacol; 2017 Jan; 794():209-215. PubMed ID: 27890711
[TBL] [Abstract][Full Text] [Related]
19. The effects of Delta9-tetrahydrocannabinol in rat mesenteric vasculature, and its interactions with the endocannabinoid anandamide.
O'Sullivan SE; Kendall DA; Randall MD
Br J Pharmacol; 2005 Jun; 145(4):514-26. PubMed ID: 15821751
[TBL] [Abstract][Full Text] [Related]
20. Capsaicin Protects Against Cisplatin Ototoxicity by Changing the STAT3/STAT1 Ratio and Activating Cannabinoid (CB2) Receptors in the Cochlea.
Bhatta P; Dhukhwa A; Sheehan K; Al Aameri RFH; Borse V; Ghosh S; Sheth S; Mamillapalli C; Rybak L; Ramkumar V; Mukherjea D
Sci Rep; 2019 Mar; 9(1):4131. PubMed ID: 30858408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
